These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9156942)

  • 41. Effect of calcium channel blockers on intracellular calcium accumulation.
    Haag-Weber M; Hörl WH
    Nephrol Dial Transplant; 1994; 9 Suppl 3():24-7. PubMed ID: 8072720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calcium antagonists and the kidney].
    Fievet P; Boudjelal M; Demontis R; Fournier A
    Ann Med Interne (Paris); 1989; 140(7):637-43. PubMed ID: 2692495
    [No Abstract]   [Full Text] [Related]  

  • 43. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1992 Dec; 54(6):1103-6. PubMed ID: 1465778
    [No Abstract]   [Full Text] [Related]  

  • 44. Cyclosporin nephrotoxicity.
    Neild GH
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):198-203. PubMed ID: 2081228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of low-dose cyclosporine on renal function in normal subjects.
    Fuiano G; Sepe V; Cianfrone P; Libetta C; Sabbatini M; Colucci G; Conte G; Balletta M; De Nicola L
    Transplantation; 1991 Mar; 51(3):734-6. PubMed ID: 2006535
    [No Abstract]   [Full Text] [Related]  

  • 46. Attempts to improve the selectivity of calcium antagonistic drugs.
    van Zwieten PA; Pfaffendorf M; Mancia G
    Blood Press Suppl; 1996; 5():7-9. PubMed ID: 8973786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal effects of calcium antagonists.
    Rodicio JL; Campo C; Ruilope LM
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():17-22. PubMed ID: 8643202
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor.
    Eiam-Ong S; Eiam-Ong S; Punsin P; Sitprija V; Chaiyabutr N
    J Med Assoc Thai; 2004 Apr; 87(4):410-8. PubMed ID: 15217180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up.
    Wagner K; Neumayer HH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1353-7. PubMed ID: 3547865
    [No Abstract]   [Full Text] [Related]  

  • 51. Verapamil ameliorates acute cyclosporine A (CsA) nephrotoxicity and improves immunosuppression after cadaver renal transplantation.
    Dawidson I; Rooth P; Fisher D; Fry WR; Alway C; Coorpender L; Reisch J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1511-3. PubMed ID: 2652487
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.
    Ahmed K; Michael B; Burke JF
    Clin Nephrol; 1997 Nov; 48(5):307-10. PubMed ID: 9403215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal microvascular actions of calcium antagonists.
    Loutzenhiser R; Epstein M
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No clinical evidence for protective effects of calcium-channel blockers against acute renal failure.
    Hull RW; Hasbargen JA
    N Engl J Med; 1985 Dec; 313(23):1477-8. PubMed ID: 4058554
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
    Tikkanen I; Johnston CI
    Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicity of contrast media: an update.
    ten Dam MA; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):416-22. PubMed ID: 19011267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing renal effects and renal protection.
    Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1995 Dec; 13(4):S19-25. PubMed ID: 8824683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.